What is Stage 3 Data?
Per a 2021 IQVIA report. stage 3 success rate is at an all time low due to lack of available data post covid. Stage 3 in clinical studies refers to the companion data phase where outside data is required to prove a studies hypothesis using the captured data in phases 1 and 2 of the study.
Challenges of Acquiring Stage 3 Data
This has historically been one of the most challenging parts of the study due to the lack of available data, as well lack of successful completion of phases 1 and 2. Stage 3 data can be provided and leveraged in the form of both retrospective and prospective data analysis.
What Happens After Stage 3?
Once a hypothesis is proven or disproven through a companion analysis conducted with the data in stage 3 of the study, the research institutions may now enter into phase 4 which is the results phase that is the final remaining step required in the study or trial process prior to receiving FDA approval and/or go-to-market.
Where to Find Stage 3 Data
Looking for health care data? We are here to help you save time and money! If you are buying, selling, or need to add your data to our exchange let us know.